Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β. 2013

Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
From the Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, United Kingdom (A.T., H.Y., M.A.-J., M.R.B., S.S.); and Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden University, Einsteinweg, Leiden, The Netherlands (M.R.B., T.v.B., I.B.).

OBJECTIVE Myocardin, a potent transcriptional coactivator of serum response factor, is involved in vascular development and promotes a contractile smooth muscle phenotype. Myocardin levels are reduced during vascular injury, in association with phenotypic switching of smooth muscle cells (SMCs). However, the direct role of myocardin in vascular disease is unclear. RESULTS We show that re-expression of myocardin prevents the vascular injury response in murine carotid arteries, with reduced neointima formation due to decreased SMC migration and proliferation. Myocardin reduced SMC migration by downregulating platelet-derived growth factor receptor-β (PDGFRB) expression. Pdgfrb was regulated by myocardin-induced miR-24 and miR-29a expression, and antagonizing these microRNAs restored SMC migration. Furthermore, using miR-24 and miR-29a mimics, we demonstrated that miR-29a directly regulates Pdgfrb expression at the 3' untranslated region while miR-24 has an indirect effect on Pdgfrb levels. Myocardin heterozygous-null mice showed an augmented neointima formation with increased SMC migration and proliferation, demonstrating that endogenous levels of myocardin are a critical regulator of vessel injury responses. CONCLUSIONS Our results extend the function of myocardin from a developmental role to a pivotal regulator of SMC phenotype in response to injury, and this transcriptional coactivator may be an attractive target for novel therapeutic strategies in vascular disease.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E

Related Publications

Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
November 2012, British journal of cancer,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
September 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
September 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
February 1997, Circulation,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
April 2019, Biochemical and biophysical research communications,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
March 2014, Zhonghua xin xue guan bing za zhi,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
August 2008, Gastroenterology,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
September 2011, Neuroscience,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
November 2020, Clinical laboratory,
Amarnath Talasila, and Haixiang Yu, and Matthew Ackers-Johnson, and Martine Bot, and Theo van Berkel, and Martin R Bennett, and Ilze Bot, and Sanjay Sinha
February 2017, Molecular carcinogenesis,
Copied contents to your clipboard!